733 related articles for article (PubMed ID: 23217706)
1. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.
Sebastián C; Zwaans BM; Silberman DM; Gymrek M; Goren A; Zhong L; Ram O; Truelove J; Guimaraes AR; Toiber D; Cosentino C; Greenson JK; MacDonald AI; McGlynn L; Maxwell F; Edwards J; Giacosa S; Guccione E; Weissleder R; Bernstein BE; Regev A; Shiels PG; Lombard DB; Mostoslavsky R
Cell; 2012 Dec; 151(6):1185-99. PubMed ID: 23217706
[TBL] [Abstract][Full Text] [Related]
2. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.
Lin Z; Yang H; Tan C; Li J; Liu Z; Quan Q; Kong S; Ye J; Gao B; Fang D
Cell Rep; 2013 Dec; 5(6):1639-49. PubMed ID: 24332849
[TBL] [Abstract][Full Text] [Related]
3. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
Tian J; Yuan L
Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
[TBL] [Abstract][Full Text] [Related]
5. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1.
Arsiwala T; Pahla J; van Tits LJ; Bisceglie L; Gaul DS; Costantino S; Miranda MX; Nussbaum K; Stivala S; Blyszczuk P; Weber J; Tailleux A; Stein S; Paneni F; Beer JH; Greter M; Becher B; Mostoslavsky R; Eriksson U; Staels B; Auwerx J; Hottiger MO; Lüscher TF; Matter CM
J Mol Cell Cardiol; 2020 Feb; 139():24-32. PubMed ID: 31972266
[TBL] [Abstract][Full Text] [Related]
6. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
Choe M; Brusgard JL; Chumsri S; Bhandary L; Zhao XF; Lu S; Goloubeva OG; Polster BM; Fiskum GM; Girnun GD; Kim MS; Passaniti A
J Cell Biochem; 2015 Oct; 116(10):2210-26. PubMed ID: 25808624
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
8. [Function of SIRT6 in tumor initiation and progression].
Dong Z; Lei Q; Liu L; Cui H
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):870-879. PubMed ID: 29019209
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
[TBL] [Abstract][Full Text] [Related]
10. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity.
Cai J; Zuo Y; Wang T; Cao Y; Cai R; Chen FL; Cheng J; Mu J
Oncogene; 2016 Sep; 35(37):4949-56. PubMed ID: 26898756
[TBL] [Abstract][Full Text] [Related]
11. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.
Zhong L; D'Urso A; Toiber D; Sebastian C; Henry RE; Vadysirisack DD; Guimaraes A; Marinelli B; Wikstrom JD; Nir T; Clish CB; Vaitheesvaran B; Iliopoulos O; Kurland I; Dor Y; Weissleder R; Shirihai OS; Ellisen LW; Espinosa JM; Mostoslavsky R
Cell; 2010 Jan; 140(2):280-93. PubMed ID: 20141841
[TBL] [Abstract][Full Text] [Related]
13. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract][Full Text] [Related]
14. SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity.
Ioris RM; Galié M; Ramadori G; Anderson JG; Charollais A; Konstantinidou G; Brenachot X; Aras E; Goga A; Ceglia N; Sebastián C; Martinvalet D; Mostoslavsky R; Baldi P; Coppari R
Cell Rep; 2017 Feb; 18(8):1858-1868. PubMed ID: 28228253
[TBL] [Abstract][Full Text] [Related]
15. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming.
Zwaans BM; Lombard DB
Dis Model Mech; 2014 Sep; 7(9):1023-32. PubMed ID: 25085992
[TBL] [Abstract][Full Text] [Related]
16. SIRT6: a master epigenetic gatekeeper of glucose metabolism.
Zhong L; Mostoslavsky R
Transcription; 2010; 1(1):17-21. PubMed ID: 21327158
[TBL] [Abstract][Full Text] [Related]
17. Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer.
Kugel S; Feldman JL; Klein MA; Silberman DM; Sebastián C; Mermel C; Dobersch S; Clark AR; Getz G; Denu JM; Mostoslavsky R
Cell Rep; 2015 Oct; 13(3):479-488. PubMed ID: 26456828
[TBL] [Abstract][Full Text] [Related]
18. α-Hederin inhibits the growth of lung cancer A549 cells
Fang C; Liu Y; Chen L; Luo Y; Cui Y; Zhang N; Liu P; Zhou M; Xie Y
Pharm Biol; 2021 Dec; 59(1):11-20. PubMed ID: 33356727
[TBL] [Abstract][Full Text] [Related]
19. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder.
Wu M; Dickinson SI; Wang X; Zhang J
Int J Clin Exp Pathol; 2014; 7(10):6504-13. PubMed ID: 25400728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
